Desmopressin ( DrugBank: Desmopressin )


5 diseases
IDDisease name (Link within this page)Number of trials
6Parkinson disease2
64Thrombotic thrombocytopenic purpura1
72Pituitary ADH secretion disorder1
225Congenital nephrogenic diabetes insipidus1
288Autoimmune acquired coagulation factor deficiency6

6. Parkinson disease


Clinical trials : 2,307Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

64. Thrombotic thrombocytopenic purpura


Clinical trials : 92Drugs : 85 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 76 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

72. Pituitary ADH secretion disorder


Clinical trials : 41Drugs : 27 - (DrugBank : 8) / Drug target genes : 7 - Drug target pathways : 10 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

225. Congenital nephrogenic diabetes insipidus


Clinical trials : 15Drugs : 48 - (DrugBank : 18) / Drug target genes : 31 - Drug target pathways : 65 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

288. Autoimmune acquired coagulation factor deficiency


Clinical trials : 206Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries